One such study utilized the UK Biobank dataset to develop a genetic risk score for NAFLD, considering the combined effects of variants involved in hepatic fat accumulation (PNPLA3-TM6SF2-MBOAT7-GCKR) [51]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.